Journal session: Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE) : a phase 3, randomised-controlled, non-inferiority trial.
Rotating resident: Nithina Y.
Fellow: Natcha S.
9.00 – 10.00 a.m.
I.D. Conference Room - 14-floor Bldg
For more, please visit
http://www.idchula.org/
